Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | ADC payloads to Fc mutations: advancing bioanalysis for novel modalities 4 days 18 hours 41 mins 4 secs SAVE YOUR SEAT!

Video: APA 2015 – Reaching new heights in targeted quantitation with HRMS

15 Mar 2016
Written by Mark Wrona (Waters Corporation)
Chromatography MS (LC–MS/MS, HRMS, IMS)

https://www.youtube.com/watch?v=62i-2wAEAWgMark Wrona, Senior Science Manager at Waters Corporation, discusses the use of high resolution mass spectrometry (HRMS) for targeted quantitation studies. This presentation was originally given at APA 2015 in Boston (MA, USA).

Top content

  • A new blood test for chronic fatigue syndrome: fatigue finally figured out?
  • Why your lab’s best investment isn’t equipment – it’s education
  • Expanding the AAV analytical toolkit for gene therapies

Related tags

HRMS microfluidics
Previous article Next article

Related articles

24 MAR 2016 AUTOMATION
Validation of an integrated series of ligand-binding assays for the quantitative determination of antibody–drug conjugates in biological matrices
17 APR 2014 GENERAL INTEREST
Sticky tape valves for microfluidic devices
24 AUG 2016 JOURNAL ARTICLES
A workflow for absolute quantitation of large therapeutic proteins in biological samples at intact level using LC-HRMS
3 MAY 2016 NEWS
Ultrasensitive microfluidic chip could improve diabetes diagnoses
2 MAR 2018 EXPERT OPINION
Ask the Experts: Timothy Garrett
11 AUG 2015 CHROMATOGRAPHY
Integration of microfluidic LC with HRMS for the analysis of analytes in biofluids: past, present and future
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone